Polypharmacology in drug discovery /

"Covers the two-sided nature of polypharmacology--its contribution to adverse drug reactions and its benefit in certain therapeutic drug classes. Addresses the important topic of polypharmacology in drug discovery, a subject that has not been thoroughly covered outside of scattered journal arti...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Peters, Jens-Uwe
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Hoboken, N.J. : Wiley, [2012]
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 06745nam a2200865 4500
001 ocn779410061
003 OCoLC
005 20170124071607.4
006 m o d
007 cr cnu---unuuu
008 120306s2012 njua ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d UIU  |d DG1  |d YDXCP  |d CDX  |d IUL  |d OCLCQ  |d MYG  |d E7B  |d COO  |d NLGGC  |d OCLCF  |d RECBK  |d NLE  |d MHW  |d IDEBK  |d OCLCQ  |d D6H  |d OCLCQ  |d AZK  |d GrThAP 
019 |a 784124194  |a 811493986  |a 839336010  |a 860514925  |a 898985525  |a 961529870  |a 962708756 
020 |a 9781118098141 
020 |a 1118098145 
020 |a 9781118098127 
020 |a 1118098129 
020 |a 9781280589324  |q (MyiLibrary) 
020 |a 1280589329  |q (MyiLibrary) 
020 |a 9781118098134  |q (electronic bk.) 
020 |a 1118098137  |q (electronic bk.) 
020 |z 9780470590904 
020 |z 0470590904 
028 0 1 |a EB00062625  |b Recorded Books 
029 1 |a AU@  |b 000049014066 
029 1 |a DEBBG  |b BV042794916 
029 1 |a DEBBG  |b BV043394309 
029 1 |a DKDLA  |b 820120-katalog:000600378 
029 1 |a NLGGC  |b 340803193 
029 1 |a NZ1  |b 14976855 
029 1 |a ZWZ  |b 17893285X 
035 |a (OCoLC)779410061  |z (OCoLC)784124194  |z (OCoLC)811493986  |z (OCoLC)839336010  |z (OCoLC)860514925  |z (OCoLC)898985525  |z (OCoLC)961529870  |z (OCoLC)962708756 
037 |a 10.1002/9781118098141  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a RM301.25  |b .P65 2012eb 
060 4 |a QV 744 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
082 0 4 |a 615.19  |2 23 
084 |a 44.42  |2 bcl 
049 |a MAIN 
245 0 0 |a Polypharmacology in drug discovery /  |c edited by Jens-Uwe Peters. 
264 1 |a Hoboken, N.J. :  |b Wiley,  |c [2012] 
264 4 |c ©2012 
300 |a 1 online resource (xxiii, 510 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
380 |a Bibliography 
520 |a "Covers the two-sided nature of polypharmacology--its contribution to adverse drug reactions and its benefit in certain therapeutic drug classes. Addresses the important topic of polypharmacology in drug discovery, a subject that has not been thoroughly covered outside of scattered journal articles. Overviews state-of-the-art approaches and developments to help readers understand concepts and issues related to polypharmacology."--  |c Provided by publisher. 
520 |a "An essential outline of the main facets of polypharmacology in drug discovery research. Extending drug discovery opportunities beyond the "one drug, one target" philosophy, a polypharmacological approach to the treatment of complex diseases is emerging as a hot topic in both industry and academic research. Polypharmacology in Drug Discovery presents an overview of the various facets of polypharmacology and how it can be applied as an innovative concept for developing medicines for treating bacterial infections, epilepsy, cancer, psychiatric disorders, and more."--  |c Provided by publisher. 
504 |a Includes bibliographical references and index. 
505 0 |a Frontmatter -- Color Plates -- Introduction: The Case for Polypharmacology / Andrew L Hopkins -- Polypharmacology: A Safety Concern in Drug Discovery. The Relevance of Off-Target Polypharmacology / Bruce D Car -- Screening for Safety-Relevant Off-Target Activities / Laszlo Urban, Steven Whitebread, Jacques Hamon, Dmitri Mikhailov, Kamal Azzaoui -- Pharmacological Promiscuity and Molecular Properties / Jens-Uwe Peters -- Kinases as Antitargets in Genotoxicity / Stephan Kirchner -- Activity at Cardiovascular Ion Channels: A Key Issue for Drug Discovery / Ian M Bell, Mark T Bilodeau, Armando A Lagrutta -- Prediction of Side Effects Based on Fingerprint Profiling and Data Mining / Jacques Migeon -- Polypharmacology: An Opportunity for Drug Discovery. Polypharmacological Drugs: ₃Magic Shotguns₄ for Psychiatric Diseases / Wesley K Kroeze, Bryan L Roth -- Polypharmacological Kinase Inhibitors: New Hopes for Cancer Therapy / Annalisa Petrelli -- Polypharmacology as an Emerging Trend in Antibacterial Discovery / Lynn L Silver -- A ₃Magic Shotgun₄ Perspective on Anticonvulsant Mechanisms / Matt T Bianchi, Kathy Chuang -- Selective Optimization of Side Activities (SOSA): A Promising way for Drug Discovery / Thierry Langer, Camille-Georges Wermuth -- Selected Approaches to Polypharmacological Drug Discovery. Selective Multitargeted Drugs / Richard Morphy -- Computational Multitarget Drug Discovery / Jeremy A Horst, Adrian Laurenzi, Brady Bernard, Ram Samudrala -- Behavior-Based Screening as an Approach to Polypharmacological Ligands / Dani Brunner, Vadim Alexandrov, Barbara Caldarone, Taleen Hanania, David Lowe, Jeff Schneider, Jayaraman Chandrasekhar -- Multicomponent Therapeutics / Alexis A Borisy, Grant R Zimmermann, Joseph Leh̀r -- Case Studies. Discovery of Sunitinib as a Multitarget Treatment of Cancer / Catherine Delbaldo, Camelia Colichi, Marie-Paule Sablin, Chantal Dreyer, Bertrand Billemont, Sandrine Faivre, Eric Raymond -- Antipsychotics / Claus Riemer -- Triple-Uptake Inhibitors (Broad-Spectrum Antidepressants) / Phil Skolnick -- Therapeutic Potential of Small Molecules Modulating the Cyclooxygenase₆5-Lipoxygenase Pathway / Wolfgang Albrecht, Stefan Laufer -- Drug Research Leading to Imatinib and beyond to Nilotinib / Paul W Manley, Jorg Zimmermann -- Towards Antimalarial Hybrid Drugs / Bernard Meunier -- Multitargeted Drugs for Treatment of Alzheimer's Disease / Andrea Cavalli, Maria Laura Bolognesi -- Carbonic Anhydrases: Off Targets, Add-On Activities, or Emerging Novel Targets? / Claudiu T Supuran -- Index. 
588 0 |a Print version record. 
650 0 |a Drug development. 
650 0 |a Drugs  |x Toxicology. 
650 0 |a Pharmacology. 
650 4 |a Medical. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Drugs  |x Toxicology.  |2 fast  |0 (OCoLC)fst00898958 
650 7 |a Pharmacology.  |2 fast  |0 (OCoLC)fst01060259 
650 1 2 |a Drug Discovery. 
650 2 2 |a Drug Toxicity. 
650 2 2 |a Pharmaceutical Preparations  |x chemistry. 
655 4 |a Electronic books. 
700 1 |a Peters, Jens-Uwe. 
776 0 8 |i Print version:  |t Polypharmacology in drug discovery.  |d Hoboken, N.J. : Wiley, ©2011  |z 9780470590904  |w (DLC) 2011052324  |w (OCoLC)714728070 
856 4 0 |u https://doi.org/10.1002/9781118098141  |z Full Text via HEAL-Link 
994 |a 92  |b DG1